BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 11264546)

  • 1. A rapid test for B-type natriuretic peptide correlates with falling wedge pressures in patients treated for decompensated heart failure: a pilot study.
    Kazanegra R; Cheng V; Garcia A; Krishnaswamy P; Gardetto N; Clopton P; Maisel A
    J Card Fail; 2001 Mar; 7(1):21-9. PubMed ID: 11264546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid assay brain natriuretic peptide and troponin I in patients hospitalized with decompensated heart failure (from the Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness Trial).
    Shah MR; Hasselblad V; Tasissa G; Christenson RH; Binanay C; O'Connor CM; Ohman EM; Stevenson LW; Califf RM
    Am J Cardiol; 2007 Nov; 100(9):1427-33. PubMed ID: 17950802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in plasma N-terminal proBNP levels and ventricular filling pressures during intensive unloading therapy in elderly with decompensated congestive heart failure and preserved left ventricular systolic function.
    Cioffi G; Tarantini L; Stefenelli C; Azzetti G; Marco R; Carlucci S; Furlanello F
    J Card Fail; 2006 Oct; 12(8):608-15. PubMed ID: 17045179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary results of the Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT). A multicenter study of B-type natriuretic peptide levels, emergency department decision making, and outcomes in patients presenting with shortness of breath.
    Maisel A; Hollander JE; Guss D; McCullough P; Nowak R; Green G; Saltzberg M; Ellison SR; Bhalla MA; Bhalla V; Clopton P; Jesse R;
    J Am Coll Cardiol; 2004 Sep; 44(6):1328-33. PubMed ID: 15364340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B-type natriuretic peptide levels: a potential novel "white count" for congestive heart failure.
    Maisel A
    J Card Fail; 2001 Jun; 7(2):183-93. PubMed ID: 11420771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. Nesiritide Study Group.
    Colucci WS; Elkayam U; Horton DP; Abraham WT; Bourge RC; Johnson AD; Wagoner LE; Givertz MM; Liang CS; Neibaur M; Haught WH; LeJemtel TH
    N Engl J Med; 2000 Jul; 343(4):246-53. PubMed ID: 10911006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Admission B-type natriuretic peptide levels and in-hospital mortality in acute decompensated heart failure.
    Fonarow GC; Peacock WF; Phillips CO; Givertz MM; Lopatin M;
    J Am Coll Cardiol; 2007 May; 49(19):1943-50. PubMed ID: 17498579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between B-type natriuretic peptides and pulmonary capillary wedge pressure in the intensive care unit.
    Forfia PR; Watkins SP; Rame JE; Stewart KJ; Shapiro EP
    J Am Coll Cardiol; 2005 May; 45(10):1667-71. PubMed ID: 15893185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood volume and brain natriuretic peptide in congestive heart failure: a pilot study.
    James KB; Troughton RW; Feldschuh J; Soltis D; Thomas D; Fouad-Tarazi F
    Am Heart J; 2005 Nov; 150(5):984. PubMed ID: 16290978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. B-type natriuretic peptide levels are not a surrogate marker for invasive hemodynamics during management of patients with severe heart failure.
    O'Neill JO; Bott-Silverman CE; McRae AT; Troughton RW; Ng K; Starling RC; Young JB
    Am Heart J; 2005 Feb; 149(2):363-9. PubMed ID: 15846278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Baseline and serial neurohormones in patients with congestive heart failure treated with and without bucindolol: results of the neurohumoral substudy of the Beta-Blocker Evaluation of Survival Study (BEST).
    Frantz RP; Lowes BD; Grayburn PA; White M; Krause-Steinrauf H; Krishnan V; Uyeda L; Burnett JC;
    J Card Fail; 2007 Aug; 13(6):437-44. PubMed ID: 17675057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B-type natriuretic peptide and renal function in the diagnosis of heart failure: an analysis from the Breathing Not Properly Multinational Study.
    McCullough PA; Duc P; Omland T; McCord J; Nowak RM; Hollander JE; Herrmann HC; Steg PG; Westheim A; Knudsen CW; Storrow AB; Abraham WT; Lamba S; Wu AH; Perez A; Clopton P; Krishnaswamy P; Kazanegra R; Maisel AS;
    Am J Kidney Dis; 2003 Mar; 41(3):571-9. PubMed ID: 12612980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gray zone BNP levels in heart failure patients in the emergency department: results from the Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT) multicenter study.
    Brenden CK; Hollander JE; Guss D; McCullough PA; Nowak R; Green G; Saltzberg M; Ellison SR; Bhalla MA; Bhalla V; Clopton P; Jesse R; Maisel AS;
    Am Heart J; 2006 May; 151(5):1006-11. PubMed ID: 16644322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination of B-type natriuretic peptide and peak oxygen consumption improves risk stratification in outpatients with chronic heart failure.
    Isnard R; Pousset F; Chafirovskaïa O; Carayon A; Hulot JS; Thomas D; Komajda M
    Am Heart J; 2003 Oct; 146(4):729-35. PubMed ID: 14564330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic utility of B-type natriuretic peptide assessment in stable low-risk outpatients with nonischemic cardiomyopathy after decompensated heart failure.
    Nishii M; Inomata T; Takehana H; Naruke T; Yanagisawa T; Moriguchi M; Takeda S; Izumi T
    J Am Coll Cardiol; 2008 Jun; 51(24):2329-35. PubMed ID: 18549918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B-type natriuretic peptide levels in obese patients with advanced heart failure.
    Horwich TB; Hamilton MA; Fonarow GC
    J Am Coll Cardiol; 2006 Jan; 47(1):85-90. PubMed ID: 16386669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levosimendan reduces plasma B-type natriuretic peptide and interleukin 6, and improves central hemodynamics in severe heart failure patients.
    Kyrzopoulos S; Adamopoulos S; Parissis JT; Rassias J; Kostakis G; Iliodromitis E; Degiannis D; Kremastinos DT
    Int J Cardiol; 2005 Mar; 99(3):409-13. PubMed ID: 15771921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B-type natriuretic peptide (BNP) levels: diagnostic and therapeutic potential.
    Maisel AS
    Rev Cardiovasc Med; 2001; 2 Suppl 2():S13-8. PubMed ID: 12439357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Possible vascular role of increased plasma arginine vasopressin in congestive heart failure.
    Nakamura T; Funayama H; Yoshimura A; Tsuruya Y; Saito M; Kawakami M; Ishikawa SE
    Int J Cardiol; 2006 Jan; 106(2):191-5. PubMed ID: 16321691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Predictive value for long term cardiac events by admission B-type natriuretic peptide and pulmonary capillary wedge pressure in patients with chronic heart failure].
    Hu YM; Wang M; Zhao SQ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2008 Sep; 36(9):786-9. PubMed ID: 19102857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.